Temporal Enzymatic Treatment to Enhance the Remodelling of Multiple Cartilage Microtissues into a Structurally Organised Tissue.
Ross BurdisXavier Barceló GallostraDaniel John KellyPublished in: Advanced healthcare materials (2023)
Scaffold-free tissue engineering aims to recapitulate key aspects of normal developmental processes to generate biomimetic grafts. Although functional cartilaginous tissues have been engineered using such approaches, considerable challenges remain. Herein, the benefits of engineering cartilage via the fusion of multiple cartilage microtissues compared to using (millions of) individual cells to generate a cartilaginous graft is demonstrated. Key advantages include the generation of a richer extracellular matrix, more hyaline-like cartilage phenotype, and superior shape-fidelity. A major drawback of aggregate engineering is that individual microtissues do not completely (re)model and remnants of their initial architectures remain throughout the macrotissue. To address this, a temporal enzymatic (chondroitinase-ABC) treatment is implemented to accelerate structural (re)modelling and is shown to support robust fusion between adjacent microtissues, enhance microtissue (re)modelling, and enable the development of a more biomimetic tissue with a zonally organised collagen-network. Additionally, enzymatic treatment is shown to modulate matrix composition, tissue phenotype, and to a lesser extent, tissue mechanics. This work demonstrates that microtissue self-organisation is an effective method for engineering scaled-up cartilage grafts with a predefined geometry and near-native levels of matrix accumulation. Importantly, key limitations associated with using biological building blocks can be alleviated by temporal enzymatic treatment during graft development. This article is protected by copyright. All rights reserved.